NAPIGEN

Biotechnology

Overview

Explore NAPIGEN for innovative mitochondrial and chloroplast genome editing solutions. Partner with Napp Labs for cutting-edge research!

Funding and backers

Grants
$500k
3 grants · CORDIS
Backers
1
RA Capital Management
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Feb 23, 2024 Won a grant $175k · CORDIS Jun 1, 2022 Won a grant $225k · CORDIS Jun 3, 2020 Won a grant $100k · CORDIS
Funding rounds
RoundDateAmountInvestorsSource
Grant Feb 2024 $175k — CORDIS
Grant Jun 2022 $225k — CORDIS
Grant Jun 2020 $100k — CORDIS
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Precision BioSciencesVenture round $88.1M · 8 yr ago
ARCUS Genome Editing. At Precision BioSciences, we are using our novel ARCUS genome-editing technology to develop a new class of medicines…
MetagenomiVenture round $95.8M · 3 yr ago · Founded 2018
Metagenomi is an in vivo genome editing company capitalizing on its proprietary technologies to create curative genetic medicines for…
Qihan BiotechSeries A · 3 yr ago · Founded 2017
Co-founded in 2017 by two pioneers in genome editing technology, Qihan Biotech has world-leading capabilities in multiplexable genome…
Pioneering next generation therapeutics through cutting-edge research and AI-powered drug discovery.
Nyctea Tech is advancing life science through innovative biotechnology solutions, combining cutting-edge research with practical…
ElFysFounded 2017
Explore ElFys – the leader in photodetector technology. Discover our innovative products, cutting-edge research, and solutions for diverse…

Financials

Total raised
$500k
Latest round
Grant
Funding rounds
3
Funding rounds
Round Announced Amount
Grant 2024 $175k Details
Grant 2022 $225k Details
Grant 2020 $100k Details

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors1
222 portfolio companies: Verdiva Bio, PLEASE READ THIS AG, Vivace Therapeutics and 219 more

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Wilmington United States
HQ
ABOUT US
200 Powder Mill Rd. | DIS-E500 | Wilmington, DE 19803
company site